Somatostatin Receptor Scintigraphy for Bronchial Carcinoid Follow-Up

Clinical Nuclear Medicine

Volumn 28, Issue 7, 2003, Pages 548-552

  Fanti, Stefano ^a   Farsad, Mohsen ^a   Battista, Giuseppe ^a   Monetti, Francesco ^a   Montini, Gian Carlo ^a   Chiti, Arturo ^c   Savelli, Giordano ^b   Petrella, Francesco ^a   Bini, Alessandro ^a   Nanni, Cristina ^a   Romeo, Annadina ^a   Franchi, Roberto ^a   Bombardieri, Emilio ^b   Canini, Romeo ^a   Monetti, Nino ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Bronchial Carcinoid; Somatostatin Receptor Scintigraphy

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; SDZ 215 811; SDZ 215-811;

ADULT; AGED; ARTICLE; BRONCHUS CARCINOID; CANCER SCINTISCANNING; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; THORAX RADIOGRAPHY; BRONCHUS TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BRONCHIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 10744233746     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200307000-00003     Document Type: Article

References (30)

1. Davila DG, Dunn WF, Tazelaar HD, et al: Bronchial carcinoid tumors. Mayo Clin Proc 68:795, 1993.
2. Dasmet ME, McKneally MF: Pulmonary and thymic carcinoid tumors. World J Surg 20:189, 1996.
3. Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 79:813, 1997.
4. Caplin ME, Buscombe JR, Hilson AJ, et al: Carcinoid tumor. Lancet 352:799, 1998.
5. Creutzfeldt W: Carcinoid tumors: development of our knowledge. World J Surg 20:126, 1996.
6. Shah R, Sabanathan S, Means J, et al: Carcinoid tumour of the lung. J Cardiovasc Surg 38:187, 1997.
7. Froudarakis M, Fournel P, Burgard G, et al: Bronchial carcinoids. A review of 22 cases. Oncology 53:153, 1996.
8. Paladugo RR, Benfield JR, Pak HY, et al: Broncholpulmonary Kulchitsky cell carcinomas. A new classification scheme for typical and atypical carcinoids. Cancer 55:1303, 1958.
9. Arrigoni MG, Woolner LB, Bernatz PE: Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64:413, 1972.
10. Musi M, Carbone RG, Bertocchi C, et al: Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer 22:97, 1998.
11. Perkins P, Kemp BL, Putman JB, et al: Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior. Am J Clin Oncol 20:285, 1997.
12. Harpole DH, Feldman JM, Buchanan S, et al: Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann Thorac Surg 54:50, 1992.
13. Martini N, Zaman MB, Bains MS, et al: Treatment and prognosis in bronchial carcinoids involving regional lymph nodes. J Thorac Cardiovasc Surgery 107:1, 1994.
14. Vinik AL, Moattari AR, Pavlic-Renar I, et al: Tumori endocrini del pancreas: aspetti medici. In: Burns GP, Bank S, eds. Malattie del Pancreas. Milan: McGraw-Hill Libri Italia, 1993, pp 391-434.
15. Felldman JM, O'Dorisio TM: Role of neuropeptides and serotonin in the diagnosis of carcinoid tumours. Am J Med 81(Suppl 6B):41, 1986.
16. O'Byrne KJ, O'Hare NJ, Freyne PJ, et al: Imaging of bronchial carcinoid tumours with indium-111 pentetreotide. Thorax 49: 284, 1994.
17. Kwekkeboom DJ, Krenning EP, Bakker WH, et al: Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20:283, 1993.
18. Nguyen BD, Roarke MC, Umfrid RP, et al: Technetium-99m sestamibi SPECT imaging of bilateral pulmonary carcinoid tumors. Clin Nucl Med 25:456, 2000.
19. Arbab AS, Koizumi K, Arai T, et al: Tc-99m MIBI uptake in a bronchial carcinoid tumor. Clin Nucl Med 21:1005, 1996.
20. Koh E, Patrikeos A, Steens R, et al: Hilar bronchial carcinoid tumor: increased peritumoral vascular expression of somatostatin-2 receptor on an octeotide study? Clin Nucl Med 26:870, 2001.
21. Villa G, Ratto GB, Carletto M, et al: The incidental discovery of follicular thyroid cancer with In-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lung. Clin Nucl Med 28:45, 2003.
22. Duarte PS, Zhuang H, Gusmao M, et al: In-111 octreotide uptake in the thymus in a patient with Cushing's syndrome. Clin Nucl Med 27:453, 2002.
23. Garancini S, La Rosa S, De Palma D, et al: Uptake of In-111 pentetreotide by normally functioning nodular goiters. Clin Nucl Med 22:625, 1997.
24. Silva F, Vasquez-Selles J, Aguilo F, et al: Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging. Clin Nucl Med 24:109, 1999.
25. Fanti S, Bellanova B, Chiti A, et al: Somatostatin receptor scintigraphy in a patient with an epigastric mass and multiple liver metastases. Clin Nucl Med 22:802, 1997.
26. Nguyen BD, Chin BB, Beall DP: In-111 pentetreotide SPECT imaging of carcinoid tumor of duodenum. Clin Nucl Med 22: 781, 1997.
27. Hoegerle S, Nitzsche EU, Stumpf A, et al: Incidental appendix carcinoid. Value of somatostatin receptor imaging. Clin Nucl Med 22:467, 1997.
28. Krenning EP, Kwekkeboom DJ, Bakker WH, et al: Somatostatin receptor scintigraphy with 111In-DTPA-Phe and 123I-Tyr Octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716, 1993.
29. Wenham S, Collins CD: Carcinoid syndrome in the absence of hepatic metastases: correlation of CT and In-111 octreotide imaging. Clin Nucl Med 24:800, 1999.
30. Ahlman H, Westberg G, Wänberg B, et al: Treatment of liver metastases of carcinoid tumors. World J Surg 20:196, 1996.